• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

Labour epidural analgesia not associated with autism spectrum disorder

byJake EngelandMichael Pratte
September 29, 2021
in Obstetrics, Pediatrics, Psychiatry
Reading Time: 2 mins read
Social networks play key roles in parental vaccination decisions
Share on FacebookShare on Twitter

1. This large, nationwide, Danish cohort study found no increased risk of autism spectrum disorder in children exposed to labour epidural analgesia compared to those without exposure.

Evidence Rating Level: 2 (Good)

Study Rundown: A recent study observed an increased incidence of autism in children born from mothers who received labour epidural analgesia compared to those born without epidural analgesia. This nationwide Danish cohort study, including all live-born children from January 1, 2006, until December 31, 2013, investigated whether there was an increased risk of autism spectrum disorder (ASD) in children following administration of labour epidural analgesia. The primary outcome was the incidence of ASD. Follow-up began after the child-first birthday. Among 479 178 eligible children, 92 900 (19.4%) were exposed to labour epidural analgesia. The median follow-up was 7.0 years (IQR: 4.9-9.0). Some baseline characteristics differed between mothers who received labour epidural versus no labour epidural analgesia; therefore, adjusted analyses were presented. The incidence rate of ASD was 23.1 per 10 000 person-years in children exposed to labour epidural analgesia compared to 18.5 per 10 000 person-years in those without exposure (adjusted hazard ratio [HR]: 1.05 [95% CI: 0.98-1.11]). Furthermore, a within-mother analysis design was explored using children of mothers with more than one delivery who had both exposure and no exposure to labour epidural analgesia. There were 59 154 children included in this analysis and similarly found no association of ASD from exposure to labour epidural analgesia (exposed incidence rate: 20.8 per 10 000 person-years; unexposed incidence rate: 17.1 per 10 000 person-years; adjusted HR: 1.05 [95% CI: 0.90-1.21]). Overall, in contrast to a recent study, the incidence of ASD was not increased among children exposed to labour epidural analgesia. One limitation of this study, however, is that ASD can be misclassified or diagnosed later in life. Follow-up for this study was adequate (median: 7 years); however, it is critical to consider that some children can be diagnosed later in their adolescent years.

Click to read the study in JAMA

Click to read an accompanying editorial in JAMA

Relevant Reading: Association between epidural analgesia during labor and risk of autism spectrum disorders in offspring

RELATED REPORTS

2 Minute Medicine Rewind July 20, 2026

A non-invasive neurostimulation intervention may improve social communication impairment in children with autism spectrum disorder

2 Minute Medicine Rewind May 4, 2026

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: autismautism spectrum disorderepiduralsthoracic epidural analgesia
Previous Post

Quadruple combination pill for hypertension is more effective at lowering blood pressure than standard dose monotherapy

Next Post

#VisualAbstract: Early iBASIS–Video Interaction to Promote Positive Parenting therapy reduced autism spectrum disorder symptom severity and diagnosis rate

RelatedReports

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Weekly Rewinds

2 Minute Medicine Rewind July 20, 2026

July 20, 2026
Quick Take: Association of Prenatal Exposure to Air Pollution with Autism Spectrum Disorder
Chronic Disease

A non-invasive neurostimulation intervention may improve social communication impairment in children with autism spectrum disorder

May 5, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Weekly Rewinds

2 Minute Medicine Rewind May 4, 2026

May 4, 2026
2 Minute Rewind November 29, 2021
Chronic Disease

Prenatal exposure to components of fine particulate matter is associated with increased risk of autism spectrum disorder

January 13, 2026
Next Post
#VisualAbstract: Early iBASIS–Video Interaction to Promote Positive Parenting therapy reduced autism spectrum disorder symptom severity and diagnosis rate

#VisualAbstract: Early iBASIS–Video Interaction to Promote Positive Parenting therapy reduced autism spectrum disorder symptom severity and diagnosis rate

Adolescents’ muscle strength associated with lower cardiometabolic risk

Wellness Check: Exercise

#VisualAbstract: Presence of anti-telomerase CD4+ Th1 immunity is associated with better outcomes in patients with melanoma

#VisualAbstract: Addition of pembrolizumab to chemotherapy improves survival in patients with advanced esophageal carcinomas

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks
  • 2 Minute Medicine Rewind October 12, 2026
  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.